Results 51 to 60 of about 105,010 (247)

Tricuspid Regurgitation: Assessment and New Frontiers

, 2017
Tricuspid regurgitation is the most frequent disease of the tricuspid valve. Of these, functional tricuspid regurgitation is the most frequent, and severe insufficiency is associated with an increasing risk of cardiovascular events and bad prognosis. The
Michel Zuber, Shingo Kuwata, Francesco Maisano, Maurizio Taramasso, Alberto Pozzoli, Fabian Nietlispach, Felix Tanner   +6 more
core   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

First-in-man Experience of a New Transcatheter Edge-to-edge Repair System Neoblazar in Patients With Severe Tricuspid Regurgitation

Cardiology Discovery
Objective:. Severe tricuspid regurgitation frequently leads to increased mortality and a poor prognosis. Transcatheter edge-to-edge repair (TEER) for tricuspid valve regurgitation has been reported as a safe alternative to traditional open-heart surgery.
Xiang Chen, Da Zhu, Maolong Su, Xu Chen, Pianpian Yan, Hongmei Wen, Bin Wang, Nianguo Dong, Xiangbin Pan, Yan Wang   +9 more
doaj   +1 more source

Transcatheter edge‐to‐edge tricuspid repair for recurrence of valvular regurgitation after left ventricular assist device and tricuspid ring implantation

ESC Heart Failure, 2020
Tricuspid regurgitation in patients with left ventricular assist device (LVAD) has a significant impact on prognosis and quality of life, and its effects on liver and renal function could negatively impact planned heart transplantation.
Martin Andreas, Marco Russo, Paul Werner, Matthias Schneider, Franziska Wittmann, Sabine Scherzer, Julia Mascherbauer, Alfred Kocher, Guenther Laufer, Dominik Wiedemann, Daniel Zimpfer   +10 more
doaj   +1 more source

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

Contemporary Approach of Tricuspid Regurgitation: Knowns, Unknowns and Future Challenges. [PDF]

Severe tricuspid regurgitation (TR) worsens heart failure and is associated with impaired survival. In daily clinical practice, patients are referred late and tricuspid valve (TV) interventions (surgical or transcatheter) are underutilized, which leads ...
Brugger, Nicolas, Samim, Daryoush, Praz, Fabien, Dernektsi, Chrisoula, Reineke, David   +4 more
core   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review

Reviews in Cardiovascular Medicine
Medical devices for tricuspid regurgitation have emerged as viable treatment options for patients who do not respond to drug therapy or who are unsuitable for open-heart surgery due to high surgical risk.
Sara Veneziano, Sabrina Trippoli, Andrea Messori, Vincenzo Calderone, Eugenia Piragine   +4 more
doaj   +1 more source

First-in-Human Implantation of a New Transcatheter Tricuspid Valve Replacement System

JACC: Case Reports, 2023
Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging.
Lars Sondergaard, MD, DMSc, Jacob Eifer Møller, MD, PhD, Ole De Backer, MD, PhD, Peter Hasse Møller-Sørensen, MD, PhD, Yanping Cheng, MD, Kasper Rossing, MD, DMSc, Morten Smerup, MD, Arshad Quadri, MD   +7 more
doaj   +1 more source